Sort   by:  
 Page size 
UnknownQuality of Life Outcomes for Cabozantinib Versus Everolimus in Patients With Metastatic Renal Cell Carcinoma: METEOR Phase III Randomized Trial.
Not available
S-EPMC6804841 | biostudies-literature
UnknownTivozanib versus sorafenib as initial targeted therapy for patients with metastatic renal cell carcinoma: results from a phase III trial.
Not available
S-EPMC5569677 | biostudies-literature
UnknownMultiple lineages of monkeypox virus detected in the United States, 2021-2022.
Not available
S-EPMC10258808 | biostudies-literature
UnknownCabozantinib in Combination With Atezolizumab for Advanced Renal Cell Carcinoma: Results From the COSMIC-021 Study.
Not available
S-EPMC8601305 | biostudies-literature
UnknownEstimands for Clinical Effectiveness of Risk-Reducing Early Salpingectomy in Women With High Risk of Ovarian Cancer.
Not available
S-EPMC12441877 | biostudies-literature
UnknownImproved survival with vemurafenib in melanoma with BRAF V600E mutation.
Not available
S-EPMC3549296 | biostudies-literature
UnknownStatin treatment and muscle symptoms: series of randomised, placebo controlled n-of-1 trials.
Not available
S-EPMC7903384 | biostudies-literature
UnknownAdmission avoidance in tonsillitis and peritonsillar abscess: A prospective national audit during the initial peak of the COVID-19 pandemic.
Not available
S-EPMC7753410 | biostudies-literature
Unknown'Matching Michigan': a 2-year stepped interventional programme to minimise central venous catheter-blood stream infections in intensive care units in England.
Not available
S-EPMC3585494 | biostudies-literature
UnknownCost-effectiveness of Aflibercept Monotherapy vs Bevacizumab First Followed by Aflibercept If Needed for Diabetic Macular Edema.
Not available
S-EPMC9896372 | biostudies-literature
Sort   by:  
 Page size